MEBO Research is most grateful to the hundreds of applicants who answered the pre-screening questions below in an effort to become participants in the uBiome funded MEBO Gut Microbiome Study, "Microbial Basis of Systemic Malodor and PATM Conditions (PATM)" registered with ClinicalTrials.gov.
We are no longer recruiting participants for this study
All 100 applicants from around the world have been selected and have received their kits for sample collection. We are no longer recruiting participants for this study, though anyone interested in being considered for future research and/or testing participation opportunities with MEBO may send me a private email with the answers to the questions (click on icon below) to be placed in the MEBO Master Database. Answers to the questions may be sent to maria.delatorre@meboresearch.org .  |
| Click on icon for questions |
The following is a timeline of this research study:
May 8, 2018
MEBO awarded a study grant from UBIOME
June 10, 2018
Fundraiser to support international shipments to participants (Customs fees, return shipping cost)
Donations "Gut Microbiota in Idiopathic Malodor Production" Research
June 27, 2018
Q&A RE: MEBO Gut Microbiome Study funded by a uBiome Grant
July 2, 2018
Consent, Procedure & Life Quality Test Forms MEBO Microbiome Study
Much gratitude goes to all who applied to participate in any and all MEBO test and/or research program.
María
María de la TorreFounder and Executive Director
A Public Charity
maria.delatorre@meboresearch.com
www.meboresearch.org
MEBO's Blog (English)
El Blog de MEBO (español)
MEBO Brasil - Blog (Portuguese)
SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.
![[Facebook Share]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vtJ3urCNcEhyLTIYVkykIgNLTozjEtiaUEBvxcy7UeolUfJd2X-WIs1l89AFbiXMbFwuDUvCw3s4ftp-S22y0J-DFO92U=s0-d){kind=small}
UK 
Spain 
2 comments:
If fecal transplant can help, why is it limited to patients with c-diff
Probably due to lack of research for other conditions. Without research, there is too much uncertainty about the outcome of any procedure or medication.